Company Research Report: myTomorrows

Company Overview

• Name: myTomorrows

• Mission: To enable better and earlier access to all possible treatment options for patients, bridging the gap between those searching for all possible options and the BioPharma companies who develop them.

• Founded: 2012

• Founder: Ronald Brus, MD

• Key People:

• Michel van Harten, MD - CEO

• Dennis Akkaya - Chief Commercial Officer

• Emma Malschaert – Chief Operating Officer

• Karlijn Doorn - Head of Pharma Partnerships and Customer Success

• Danny den Hamer, PharmD - Product Manager

• Laura Cox - Director, Partnerships Development

• Headquarters: Anthony Fokkerweg 61, 1059 CP, Amsterdam, The Netherlands

• Number of Employees: Over 80

• Revenue: No information is available

• Known For: Connecting patients and physicians with clinical trials and expanded access programs.

Products

• Platform for Patients:

• Offers personalized patient navigation and easy access resources to support treatment discovery.

• Key Features:

• Patient Navigators for consultation.

• Access to clinical trials and expanded access programs.

• Platform for Healthcare Professionals:

• Provides tools for healthcare professionals to efficiently connect and provide access to treatments.

• Key Features:

• State-of-the-art search technology.

• Support for expanded access requests.

• Platform for BioPharma:

• Acts as a hub to support patient recruitment and real-world data collection.

• Key Features:

• Efficient connection with patients and trial sites.

• Improved transparency in the clinical trial process.

Recent Developments

• New Products/Features:

• TrialSearch AI: An AI-supported clinical trial search tool launched to help physicians find appropriate treatment options for patients.

• New AI-backed recruiting tool for physician-led clinical trial screening.

• Recent Partnerships:

• Partnership with CureLGMD2i to improve clinical trial access for Limb Girdle Muscular Dystrophy.

• Collaboration with Pancreatic Cancer Europe to enhance clinical trial access for pancreatic cancer patients.

• Association with brainstrust supporting patients with brain cancer.

• Partnership with The ALS Association in the US to support ALS patients in accessing clinical trials.

• Notable Leadership Changes:

• Appointment of Vanessa Lemarié as Chief Operating Officer in November 2024.

• Appointment of Marshall Van Beurden as Chief Technology Officer in July 2024.

Through its innovations and partnerships, myTomorrows continues to expand its reach and improve access to treatment and clinical trials for patients around the world.